Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtrer
Plus de filtres








Gamme d'année
1.
Braz. j. infect. dis ; Braz. j. infect. dis;25(1): 101539, jan., 2021. tab, graf
Article de Anglais | LILACS | ID: biblio-1249301

RÉSUMÉ

ABSTRACT Background: Community-genotype methicillin-resistant Staphylococcus aureus (CG-MRSA) emerged in the 1990s as a global community pathogen primarily involved in skin and soft tissue infections (SSTIs) and pneumonia. To date, the CG-MRSA SSTI burden in Latin America (LA) has not been assessed. Objective: The main objective of this study was to report the rate and genotypes of community-genotype methicillin-resistant Staphylococcus aureus (CG-MRSA) causing community-onset skin and soft tissue infections (CO-SSTIs) in LA over the last two decades. In addition, this research determined relevant data related to SSTIs due to CG-MRSA, including risk factors, other invasive diseases, and mortality. Data sources: Relevant literature was searched and extracted from five major databases: Embase, PubMed, LILACS, SciELO, and Web of Science. Methods: A systematic review was performed, and a narrative review was constructed. Results: An analysis of 11 studies identified epidemiological data across LA, with Argentina presenting the highest percentage of SSTIs caused by CG-MRSA (88%). Other countries had rates of CG-MRSA infection ranging from 0 to 51%. Brazil had one of the lowest rates of CG-MRSA SSTI (4.5-25%). In Argentina, being younger than 50 years of age and having purulent lesions were predictive factors for CG-MRSA CO-SSTIs. In addition, the predominant genetic lineages in LA belonged to sequence types 8, 30, and 5 (ST8, ST30, and ST5). Conclusion: There are significant regional differences in the rates of CG-MRSA causing CO-SSTIs. It is not possible to conclude whether or not CG-MRSA CO-SSTIs resulted in more severe SSTI presentations or in a higher mortality rate.


Sujet(s)
Humains , Infections à staphylocoques/traitement médicamenteux , Infections à staphylocoques/épidémiologie , Infections cutanées à staphylocoques/traitement médicamenteux , Infections cutanées à staphylocoques/épidémiologie , Infections communautaires/traitement médicamenteux , Infections communautaires/épidémiologie , Infections des tissus mous/traitement médicamenteux , Infections des tissus mous/épidémiologie , Staphylococcus aureus résistant à la méticilline/génétique , Argentine , Brésil , Génotype , Amérique latine/épidémiologie , Antibactériens/usage thérapeutique
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE